Christopher H. Yaen

Array ( [id] => 6340727 [patent_doc_number] => 20020034514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Delivery system to modulate immune response' [patent_app_type] => new [patent_app_number] => 09/978112 [patent_app_country] => US [patent_app_date] => 2001-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7304 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20020034514.pdf [firstpage_image] =>[orig_patent_app_number] => 09978112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1170315 [patent_doc_number] => 06749846 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-15 [patent_title] => 'Interferon-beta use in the treatment of ewing\'s family of tumors' [patent_app_type] => B1 [patent_app_number] => 09/958274 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 6286 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/749/06749846.pdf [firstpage_image] =>[orig_patent_app_number] => 09958274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664726 [patent_doc_number] => 20030204052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Novel proteins and nucleic acids encoding same and antibodies directed against these proteins' [patent_app_type] => new [patent_app_number] => 09/970944 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55502 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20030204052.pdf [firstpage_image] =>[orig_patent_app_number] => 09970944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786338 [patent_doc_number] => 20020159992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Antiangiogenic polypeptides and methods for inhibiting angiogenesis' [patent_app_type] => new [patent_app_number] => 09/967386 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10757 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20020159992.pdf [firstpage_image] =>[orig_patent_app_number] => 09967386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6466433 [patent_doc_number] => 20020150914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Recombinant antibodies from a phage display library, directed against a peptide-MHC complex' [patent_app_type] => new [patent_app_number] => 09/957113 [patent_app_country] => US [patent_app_date] => 2001-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15191 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20020150914.pdf [firstpage_image] =>[orig_patent_app_number] => 09957113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1056462 [patent_doc_number] => 06855685 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-15 [patent_title] => 'Anti-cancer agent' [patent_app_type] => utility [patent_app_number] => 09/951629 [patent_app_country] => US [patent_app_date] => 2001-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4169 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/855/06855685.pdf [firstpage_image] =>[orig_patent_app_number] => 09951629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322715 [patent_doc_number] => 07517948 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Hsp70 peptide stimulating natural killer (NK) cell activity and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/380408 [patent_app_country] => US [patent_app_date] => 2001-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10900 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517948.pdf [firstpage_image] =>[orig_patent_app_number] => 10380408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6158761 [patent_doc_number] => 20020147145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Materials and methods relating to the degradation of Cdc25A in response to DNA damage' [patent_app_type] => new [patent_app_number] => 09/949196 [patent_app_country] => US [patent_app_date] => 2001-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 24014 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147145.pdf [firstpage_image] =>[orig_patent_app_number] => 09949196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6129655 [patent_doc_number] => 20020076763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Production of a multimeric protein by cell fusion method' [patent_app_type] => new [patent_app_number] => 09/945387 [patent_app_country] => US [patent_app_date] => 2001-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8108 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20020076763.pdf [firstpage_image] =>[orig_patent_app_number] => 09945387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6570643 [patent_doc_number] => 20020165345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Prostate cancer gene' [patent_app_type] => new [patent_app_number] => 09/853526 [patent_app_country] => US [patent_app_date] => 2001-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 76271 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165345.pdf [firstpage_image] =>[orig_patent_app_number] => 09853526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064393 [patent_doc_number] => 20020032322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Family of mammalian potassium channels, their cloning and their use, especially for the screening of drugs' [patent_app_type] => new [patent_app_number] => 09/939484 [patent_app_country] => US [patent_app_date] => 2001-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11855 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20020032322.pdf [firstpage_image] =>[orig_patent_app_number] => 09939484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969013 [patent_doc_number] => 20020091081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Compositions and methods for inhibiting angiogenesis' [patent_app_type] => new [patent_app_number] => 09/935145 [patent_app_country] => US [patent_app_date] => 2001-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3519 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20020091081.pdf [firstpage_image] =>[orig_patent_app_number] => 09935145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1107330 [patent_doc_number] => 06808891 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-10-26 [patent_title] => 'Modulators of the function of FAS/APO1 receptors' [patent_app_type] => B2 [patent_app_number] => 09/933814 [patent_app_country] => US [patent_app_date] => 2001-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 17578 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/808/06808891.pdf [firstpage_image] =>[orig_patent_app_number] => 09933814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 772761 [patent_doc_number] => 07001598 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-21 [patent_title] => 'Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents' [patent_app_type] => utility [patent_app_number] => 09/931402 [patent_app_country] => US [patent_app_date] => 2001-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14771 [patent_no_of_claims] => 132 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/001/07001598.pdf [firstpage_image] =>[orig_patent_app_number] => 09931402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6241382 [patent_doc_number] => 20020044943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'MUC-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions' [patent_app_type] => new [patent_app_number] => 09/927389 [patent_app_country] => US [patent_app_date] => 2001-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7045 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20020044943.pdf [firstpage_image] =>[orig_patent_app_number] => 09927389 [rel_patent_id] =>[rel_patent_doc_number] =>)